All Posts By

Smartkarma Daily Briefs

Daily Brief Credit: Biocon Biologics – Earnings Flash – Q4 And FY 2024-25 Results – Lucror Analytics and more

By | Credit, Daily Briefs

In today’s briefing:

  • Biocon Biologics – Earnings Flash – Q4 And FY 2024-25 Results – Lucror Analytics
  • Lucror Analytics – Morning Views Asia
  • UPL Limited – Earnings Flash – FY 2024-25 Results – Lucror Analytics


Biocon Biologics – Earnings Flash – Q4 And FY 2024-25 Results – Lucror Analytics

By Trung Nguyen

  • Biocon Limited’s Q4 and FY 2024-25 results were solid in our view, with robust growth, stable profitability, as well as improved working capital and cash flows.
  • The balance sheet has strengthened, and liquidity is adequate.

Lucror Analytics – Morning Views Asia

By Leonard Law, CFA

  • In today’s Morning Views publication we comment on developments of the following high yield issuers: Seazen Group, Softbank Group
  • In the US, the April CPI came in below expectations for the third straight month at 2.3% y-o-y (2.4% e / 2.4% p) and 0.2% m-o-m (0.3% e / -0.1% p). Core CPI (excluding food and energy) stood at 2.8% y-o-y (2.8% e / 2.8% p) and 0.2% m-o-m (0.3% e / 0.1% p).

  • Treasuries were largely steady yesterday, as supply pressure from corporate issuances offset the softer than expected April CPI print.


UPL Limited – Earnings Flash – FY 2024-25 Results – Lucror Analytics

By Trung Nguyen

  • UPL Limited’s Q4 and FY 2024-25 results reflected robust revenue growth, substantial margin expansion, a return to profitability and significant debt reduction.
  • This was supported by strong operational execution and strategic initiatives across its global markets.
  • Leverage improved significantly, on account of much lower net debt and higher earnings.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Macro: USD Bears Broke The Bandwagon and more

By | Daily Briefs, Macro

In today’s briefing:

  • USD Bears Broke The Bandwagon
  • 100 days later: are all countries emerging markets now?
  • Asia Needs Self-Help
  • CX Daily: Chinese Exporters Move Quickly After Tariff Rollback, but Remain Cautious
  • Asia base oils supply outlook: Week of 12 May
  • Tariffs Add To Uncertainty In Global Tire Markets
  • Americas/EMEA base oils demand outlook: Week of 12 May
  • Global base oils arb outlook: Week of 12 May
  • Global base oils margins outlook: Week of 12 May
  • Americas/EMEA base oils supply outlook: Week of 12 May


USD Bears Broke The Bandwagon

By Phil Rush

  • Investors ask whether threats to the USD’s reserve currency status are resting or dead, whereas we wonder if it was ever alive. Commentators routinely overextend narratives.
  • The USD share of allocated FX reserves is already trending downward. A potential acceleration from smaller deficits and higher tariffs would partly offset the impact.
  • Fuller hedging of USD asset holdings abroad may have already reached its limit. We still see more attractive mispricing elsewhere, such as excessively dovish rate curves.

100 days later: are all countries emerging markets now?

By The Emerging Market Equities Podcast

  • Bob Gilhooly, a senior emerging markets economist at Aberdeen, joins the podcast to discuss Trump’s first 100 days in office and his key outcomes
  • Trump’s focus on trade deficits and tariffs has raised concerns about revenue raising and potential impact on the U.S. deficit
  • Uncertainty surrounding trade negotiations and potential outcomes continues to be a key feature of Trump’s presidency

This content is sourced through publicly available sources and has been machine generated. Information displayed is for general informational purposes only.


Asia Needs Self-Help

By Priyanka Kishore

  • Despite the ongoing trade talks and tariff de-escalation between the US and China, there is no denying that US trade barriers have risen substantially.
  • The downside risks to growth are high for export-oriented Asia and warrant a stronger policy response from central banks.
  • Their cautious approach risks a sharper slowdown and output falling further behind pre-pandemic trend.

CX Daily: Chinese Exporters Move Quickly After Tariff Rollback, but Remain Cautious

By Caixin Global

  • China-U.S. /: Chinese exporters move quickly after tariff rollback, but remain cautious
  • Whales /In Depth: The precarious fate of China’s only nearshore whales
  • Covid-19 /: New Covid wave in Hong Kong is causing severe infections in children

Asia base oils supply outlook: Week of 12 May

By Iain Pocock

  • Asia’s base oils prices hold firm vs feedstock/gasoil prices, especially for heavy grades.
  • Price-strength suggests supply-tightness continues to outweigh weaker-than-expected demand.
  • That dynamic could ease as weak demand cushions impact of recent/ongoing plant maintenance, speeds up refiners’ stock-replenishment once plants resume operations.

Tariffs Add To Uncertainty In Global Tire Markets

By Farah Miller

  • A new probe from EU on Chinese tire due to start May 19  
  • Lack of clarity on the range of tires under the scope of US auto tariff  
  • Lobbying to suspend or delay the implementation of auto tariff 

Americas/EMEA base oils demand outlook: Week of 12 May

By Iain Pocock

  • US base oils demand likely to stay weaker in face of lower feedstock costs, steady prices and expectations of improvement in supply.
  • Supply remains sufficient to cover demand even with heavy round of plant maintenance work in recent weeks.
  • Lower crude oil prices and signs of slowdown in industrial activity increase incentive to minimize stocks and procure volumes on a need-to basis.

Global base oils arb outlook: Week of 12 May

By Iain Pocock

  • Asia’s Group II base oils prices hold in relatively narrow range relative to US export prices, especially for heavy grades.
  • Steady price levels leave arbitrage from Asia to Americas hard to work, pointing to limited surplus supply.
  • US Group II light-grade export prices hold in narrow range or strengthen relative to CFR India prices since start of Q2 2025.

Global base oils margins outlook: Week of 12 May

By Iain Pocock

  • Global base oils prices mostly extend rise vs feedstock/competing fuel prices.
  • Sustained price-strength for most grades points to tight supply-demand fundamentals.
  • Price-strength incentivizes refiners to maintain or raise output.

Americas/EMEA base oils supply outlook: Week of 12 May

By Iain Pocock

  • US base oils prices hold firm vs feedstock/heating oil prices.
  • Rising margins in Q2 2025 point to tighter supply-demand fundamentals.
  • Cautious demand suggests supply is the key factor driving higher margins.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Most Read: BYD, Mayne Pharma, Hainan Meilan International Airport, GMO Internet, Pop Mart International Group L, Dawning Information Industry C, Nippon Road, Ningbo Shuanglin Auto Parts, Frasers Hospitality Trust and more

By | Daily Briefs, Most Read

In today’s briefing:

  • HSTECH Index Rebalance Preview: BYD (1211 HK) Could Replace China Literature (772 HK); Huge Trade
  • Mayne Pharma (MYX AU): MAC Musings
  • Hainan Meilan Intl Airport (357 HK): Hainan SASAC’s Left/Right Pocket MGO
  • GMO Internet (4784) Offering – This Is a GINORMOUS Re-IPO – AVOID LIKE THE PLAGUE
  • Hang Seng Index (HSI) Rebalance Preview: Inclusion Candidates for June25
  • SSE50 Index Rebalance Preview: 4 Potential Changes in June
  • [Japan M&A] – Three+ Years Later, Shimizu Comes In To Buy Out Minorities in Nippon Road (1884)
  • CSI 500/1000 Index Rebalance Preview: Strong Near-Term Outperformance
  • GMO Internet Placement: Secondary Sell-Down (Quasi IPO) To Meet Prime Listing Requirements
  • Frasers Hospitality Trust (FHT SP): Frasers Property & TCC Reload Scheme


HSTECH Index Rebalance Preview: BYD (1211 HK) Could Replace China Literature (772 HK); Huge Trade

By Brian Freitas

  • The review period for the June rebalance of the HSTECH INDEX ended on 31 March, the changes will be announced on 16 May and implemented on 6 June.
  • Following the launch of the God’s Eye ADAS, BYD (1211 HK) could become eligible for index inclusion after meeting the Autonomous theme and Innovation screening.
  • The inclusion of BYD (1211 HK) in the index could result in China Literature (772 HK) being deleted from the index in June.

Mayne Pharma (MYX AU): MAC Musings

By David Blennerhassett

  • Back on the 21st Feb 2025, Mayne Pharma (MYX AU), a leader in dermatology and women’s health, entered into a Scheme with US-based pharmaceutical outfit, Cosette Pharmaceuticals, at A$7.40/share. 
  • The transaction is progressing – the HSR Act condition was satisfied last week. A Scheme Booklet should be issued shortly, with an expected vote mid-June and late-June/early-July implementation. 
  • Shares declined 3.1% yesterday over concerns a MAC could be triggered on the back of the Trump’s executive order on pharma. The impact is likely mixed, but leans neutral.

Hainan Meilan Intl Airport (357 HK): Hainan SASAC’s Left/Right Pocket MGO

By David Blennerhassett

  • Hainan Meilan International Airport (357 HK) has announced a potential change of control, via the domestic shares. 
  • Haikou Meilan’s major shareholder, Hainan Airport Industrial, has entered into a SPA with Hainan Island (600515 CH) to sell its 50.19% stake, the completion of which triggers an unconditional MGO.
  • The H-share Offer price will be HK$10.62/share. That’s not compelling;  but it’s not meant to be as Hainan Airport Industrial and Hainan Island Construction are ultimately controlled by Hainan SASAC. 

GMO Internet (4784) Offering – This Is a GINORMOUS Re-IPO – AVOID LIKE THE PLAGUE

By Travis Lundy

  • Last year, GMO injected its internet business into GMO Internet (4784 JP) and took shares as consideration. Somehow, GMO Internet got a TOPIX inclusion earlier this year. 
  • The company has 1.24% float of 3.4mm shares. GMO Internet Group – the parent – will now offload 91.7mm shares in an equity offering to meet TSE Continued Listing Requirements.
  • That is about ¥279bn at current price against float of ¥10bn. Full market cap is ¥850bn. That’s 170x Dec25e Net Income. I expect the price will fall. You were warned. 

Hang Seng Index (HSI) Rebalance Preview: Inclusion Candidates for June25

By Brian Freitas

  • Post market close on Friday, Hang Seng Indexes will announce the changes for the Hang Seng Index (HSI INDEX) that will be implemented at the close on 6 June.
  • With no constituent changes, one-way turnover will be 1.9% with 3 stocks being capped and FAF changes for a few stocks due to a methodology change for Secondary Listings. 
  • We highlight 7 stocks that have a higher probability of being added to the index. Everything depends on the index committee, and we would not be surprised by zero changes.

SSE50 Index Rebalance Preview: 4 Potential Changes in June

By Brian Freitas

  • With the review period complete, there are 2 non-constituents in direct inclusion zone and 4 current constituents in direct deletion zone.
  • 4 changes result in a one-way turnover of 5.7%, leading to a round-trip trade of CNY 21.8bn (US$3bn). Index arb balances will increase the impact on the stocks.
  • After drifting in a range, the forecast adds have outperformed the forecast deletes over the last month. There could be further outperformance as we near the announcement date.

[Japan M&A] – Three+ Years Later, Shimizu Comes In To Buy Out Minorities in Nippon Road (1884)

By Travis Lundy

  • In February 2022, Shimizu Corp (1803 JP) bought an additional 25% to get to 50.1% of Nippon Road (1884 JP). It wasn’t a great price.
  • It was, however, a good trade to buy the dip after, as recommended. I expected Shimizu to come back in one to three years. It took three. 
  • Like last time, the price is light. The multiple is low. There are no synergies in the price analysis, in specific violation of the METI Fair M&A/CorpTakeover Guidelines.  Bah humbug.

CSI 500/1000 Index Rebalance Preview: Strong Near-Term Outperformance

By Brian Freitas

  • With the review period complete, there could be 50 changes for the CSI Smallcap 500 Index and 100 changes for the CSI 1000 Index in June.
  • There are a lot of migrations expected between the two indices and the impacts for those stocks are lower with much of the flow cancelling out.
  • The outright adds have outperformed the outright deletes over the last few months with the profit-taking in March giving way to renewed outperformance in April.

GMO Internet Placement: Secondary Sell-Down (Quasi IPO) To Meet Prime Listing Requirements

By Nicholas Tan

  • GMO Internet Group (9449 JP) is looking to sell its 33.4% stake in its subsidiary GMO Internet (4784 JP) to meet free-float requirements.
  • As the current free-float is tiny, the deal is more like a quasi-IPO rather than a placement, in our view.
  • In this note, we will talk about the deal dynamics as well as updates on the company’s financial performance.

Frasers Hospitality Trust (FHT SP): Frasers Property & TCC Reload Scheme

By David Blennerhassett

  • Frasers Hospitality Trust (FHT SP) (FHT) has announced a Scheme Implementation Deed was signed for the S-REIT’s privatisation by its current sponsor, Frasers Property Limited.
  • The Scheme Consideration is S$0.71/unit in cash against the latest adjusted NAV estimate of S$0.63904/unit (vs last NAV of S$0.64160/unit).
  • Back in September 2022, ~3% of units (~4.7% of minorities) voted against Frasers/TCC’s S$0.70/unit Offer. But only 18.8% of minorities actually voted. That deal just failed. 

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Analytics and News
  • ✓ Events & Webinars



Daily Brief Indonesia: Aneka Tambang Persero and more

By | Daily Briefs, Indonesia

In today’s briefing:

  • ANTAM (IDX: ANTM): Operational Momentum, Expansion Ahead, Valuation Still Attractive


ANTAM (IDX: ANTM): Operational Momentum, Expansion Ahead, Valuation Still Attractive

By Rahul Jain

  • ANTAM’s Q1 2025 EBITDA surged over 250% YoY, supported by strong gold and nickel sales and improved cost efficiencies.
  • Plans include new RKEF and HPAL plants in East Halmahera, targeting growth in battery-grade nickel output.
  • Despite a recent rally, ANTAM trades at just 7x forward P/E—well below regional peers—while its strong cash balance of IDR 462 per share offers downside support, stock is attractively valued.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Australia: Mayne Pharma, Insignia Financial, Webjet Group and more

By | Australia, Daily Briefs

In today’s briefing:

  • Mayne Pharma (MYX AU): High Risk/Reward as an FDA Letter Causes a Tailspin
  • Insignia Financial (IFL AU): Bain Walks Due To “Macro Uncertainty”. CC Capital’s Still In. For Now
  • Mayne Pharma (MYX AU): Firm Support From Cosette Would Be Welcome About Now
  • Webjet (WJL AU) In Play: BGH/Weiss’ NBIO And Helloworld’s Substantial Stake


Mayne Pharma (MYX AU): High Risk/Reward as an FDA Letter Causes a Tailspin

By Arun George

  • Mayne Pharma (MYX AU) shares declined 15.76% after the public disclosure of an untitled FDA letter relating to NEXTSTELLIS promotional materials
  • Mayne opines that the letter is not price sensitive as it does not prevent ongoing NEXTSTELLIS sales. Its response will likely withdraw the problematic presentation and adopt a compliance program. 
  • The scheme is unlikely to be derailed, as I estimate that the MAC clause should not be triggered in the worst-case scenario of no NEXTSTELLIS sales. Risk/reward is attractive. 

Insignia Financial (IFL AU): Bain Walks Due To “Macro Uncertainty”. CC Capital’s Still In. For Now

By David Blennerhassett

  • You could see this coming. With due diligence expected to close on the 15th May, Bain has notified  Insignia Financial (IFL AU) it won’t proceed due to macro uncertainties. 
  • Discussions remain ongoing with CC Capital. No fixed timeline on those talks, although it appears negotiations will extend beyond the 15th May.
  • NBIOs were not an ideal place to hide amid Trump’s trade war. They still aren’t. Insignia is down 14.9% as I type.

Mayne Pharma (MYX AU): Firm Support From Cosette Would Be Welcome About Now

By David Blennerhassett

  • They say bad things come in threes. First, Mayne Pharma (MYX AU)announced TherapeuticsMD (TXMD US)‘s legal lawsuit. Then shares buckled in the wake of Trump’s executive order on pharma.
  • The final straw was the FDA accusing Mayne of giving misleading impression of the risks of its oral birth control pill. Shares are now a whopping 29% adrift of terms.
  • Mayne reckons the lawsuit and the FDA letter are not materially price sensitive; and it intends to move forward with the Scheme. A similar intention from Cosette would be welcome.

Webjet (WJL AU) In Play: BGH/Weiss’ NBIO And Helloworld’s Substantial Stake

By David Blennerhassett


💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief TMT/Internet: GMO Internet, NetEase , Tencent, NVIDIA Corp, All Winner Technology, Apple , Cognizant Tech Solutions A, KLA-Tencor Corp, Automatic Data Processing, Ebay Inc and more

By | Daily Briefs, TMT/Internet

In today’s briefing:

  • GMO Internet Placement: Secondary Sell-Down (Quasi IPO) To Meet Prime Listing Requirements
  • Quiddity Leaderboard HSTECH Jun25: US$1.85bn One-Way; Announcement Soon
  • Tencent (700 HK): 1Q25, Game Revenue Up by 24% YoY, as Industry Encouraged by Authorities
  • Nvidia (NVDA US) Outlook Following $7B AI Chip Deal with Saudi Arabia
  • ChiNext/​​​ChiNext50 Index Rebalance Preview: Whole Lotta Change
  • Episode 117: Talking Apple in China with Patrick McGee
  • Cognizant Technology Solutions: Focus On Geographical & Industry Diversification For Resilience & Long-Term Value Creation!
  • KLA Corporation: The 6 Most Significant Forces Steering Its Performance into 2025 & Beyond!
  • ADP Inc.: Integration & Strategic Partnerships As a Solid Groundwork For Future Growth Opportunities!
  • eBay Is Navigating Tariffs Like a Pro—How Its China Strategy Is Fueling Global Resilience!


GMO Internet Placement: Secondary Sell-Down (Quasi IPO) To Meet Prime Listing Requirements

By Nicholas Tan

  • GMO Internet Group (9449 JP) is looking to sell its 33.4% stake in its subsidiary GMO Internet (4784 JP) to meet free-float requirements.
  • As the current free-float is tiny, the deal is more like a quasi-IPO rather than a placement, in our view.
  • In this note, we will talk about the deal dynamics as well as updates on the company’s financial performance.

Quiddity Leaderboard HSTECH Jun25: US$1.85bn One-Way; Announcement Soon

By Janaghan Jeyakumar, CFA

  • The HSTECH Index tracks the performance of the top 30 technology companies listed in Hong Kong that have high business exposure to certain technology themes.
  • The official index changes and indicative weights for the June 2025 index rebal event will be announced after the close on Friday 16th May 2025.
  • We continue to expect zero index changes for June 2025 but we estimate there to be capping flows of US$1.85bn one-way.

Tencent (700 HK): 1Q25, Game Revenue Up by 24% YoY, as Industry Encouraged by Authorities

By Ming Lu

  • In 1Q25, both total revenue and game revenue growth rates accelerated.
  • The authorities have been turning from containing games to encouraging games.
  • We expect the stock has an upside of 34% and a price target of HK$700. Buy.

Nvidia (NVDA US) Outlook Following $7B AI Chip Deal with Saudi Arabia

By Nico Rosti

  • NVIDIA stock rose over 3% Wednesday morning, after news of a reported multi-billion-dollar AI chip deal with Saudi Arabia, announced during an investment forum attended by President Trump.
  • Nvidia will supply hundreds of thousands of AI chips over five years to Humain, a new Saudi AI venture backed by the $925B Public Investment Fund.
  • Bank of America raised NVDA price target to $160 from $150. A Bloomberg report suggested the UAE may buy over 1 million Nvidia AI chips under a potential U.S. deal.

ChiNext/​​​ChiNext50 Index Rebalance Preview: Whole Lotta Change

By Brian Freitas

  • With the review period complete, we forecast 10 changes for the ChiNext Index (SZ399006 INDEX EQUITY) and 5 changes for the ChiNext 50 Index in June.
  • The largest flows will be in stocks that are adds/deletes for both indices – and there are a few of those. Plus there are some overlaps with other indices.
  • While the forecast adds have outperformed the forecast deletes for both indices since January, near-term performance has not been great. That could change as we near the announcement date.

Episode 117: Talking Apple in China with Patrick McGee

By The Circuit

  • Origin story of the book: Becoming interested in Apple’s Achilles heel in China after being too bullish on the company’s success
  • Focus on the role of manufacturing design engineers in custom manufacturing and orchestration of Apple’s supply chain in China
  • Thesis of the book: Exploring Apple’s strategic positioning in China and the symbiotic relationship between economic scale and customer allure in the luxury market

This content is sourced through publicly available sources and has been machine generated. Information displayed is for general informational purposes only.


Cognizant Technology Solutions: Focus On Geographical & Industry Diversification For Resilience & Long-Term Value Creation!

By Baptista Research

  • Cognizant Technology Solutions reported its financial performance for the first quarter of 2025, demonstrating substantial growth and strategic progress amidst an evolving macroeconomic landscape.
  • Revenue for the quarter was $5.1 billion, reflecting an 8.2% increase year-over-year in constant currency, largely driven by the acquisition of Belcan and organic growth in the Health Sciences and Financial Services sectors.
  • This growth was instrumental in placing Cognizant in what the company refers to as the “Winner’s Circle,” indicating notable progress in achieving strategic targets.

KLA Corporation: The 6 Most Significant Forces Steering Its Performance into 2025 & Beyond!

By Baptista Research

  • KLA Corporation reported strong financial results for the March quarter of 2025, with revenues of $3.06 billion, slightly exceeding the midpoint of their guidance.
  • Their non-GAAP diluted earnings per share (EPS) of $8.41 and GAAP EPS of $8.16 also met the upper end of expectations.
  • This performance was largely driven by robust demand in advanced logic, high-bandwidth memory (HBM), and significant contributions from its advanced packaging businesses.

ADP Inc.: Integration & Strategic Partnerships As a Solid Groundwork For Future Growth Opportunities!

By Baptista Research

  • Automatic Data Processing, Inc. (ADP) reported solid financial performance in its third quarter of fiscal year 2025, demonstrating robust capabilities amidst varying global economic conditions.
  • The company achieved a 6% increase in revenue, alongside a 10 basis point rise in adjusted EBIT margin and a 6% growth in adjusted EPS.
  • ADP showed significant growth across its U.S. portfolio, especially in its small business, mid-market, enterprise, and compliance solutions offerings.

eBay Is Navigating Tariffs Like a Pro—How Its China Strategy Is Fueling Global Resilience!

By Baptista Research

  • eBay Inc. began 2025 with results surpassing expectations across key financial metrics, despite a challenging operational environment triggered by ongoing trade policy changes and consumer concerns over increasing prices for imported goods.
  • The first quarter saw a nearly 2% increase in Gross Merchandise Volume (GMV) to approximately $18.8 billion, marking a consecutive streak of positive growth for four quarters.
  • The company’s revenue rose over 1% to $2.58 billion, and non-GAAP earnings per share grew by 10% to $1.38.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief South Korea: Kolmar Korea Holdings , Mini Kospi 200 Futures, Hana Financial, SK Biopharmaceuticals and more

By | Daily Briefs, South Korea

In today’s briefing:

  • Sibling Conflict Between Yoon Sang-Hyun (Brother) And Yoon Yeo-Won (Sister) At Kolmar Group
  • KRX’s In-House Derivatives Night Session: Schedule, Operational Details & Trading Considerations
  • Korean Banks; Stick with Hana (086790 KS) And Woori (316140 KS)
  • SK Biopharmaceuticals (326030 KS): Starts 2025 on Slower Note; Xcopri US Sales Growth Moderates


Sibling Conflict Between Yoon Sang-Hyun (Brother) And Yoon Yeo-Won (Sister) At Kolmar Group

By Douglas Kim

  • There is a brewing sibling conflict at the Kolmar Group. Kolmar Holdings and Kolmar BNH have clashed regarding the reorganization of Kolmar BNH’s board of directors.
  • Yoon Sang-Hyun (brother) wants to shake things up. Yoon Sang-Hyun wants to appoint new members at Kolmar BNH’s BOD but his sister Yoon Yeo-Won is opposing this. 
  • We see a higher upside for Kolmar Holdings. Our base case valuation of Kolmar Holdings is NAV per share of 14,675 won (57.5% upside from current levels).

KRX’s In-House Derivatives Night Session: Schedule, Operational Details & Trading Considerations

By Sanghyun Park

  • KRX’s night-time derivatives market goes live Monday, June 9. With Eurex ties ending June 5, this shift to in-house trading could bring flow and liquidity changes worth planning for. 
  • KRX is doubling its night session lineup from 5 to 10 products, adding KOSDAQ 150 futures/options, Mini KOSPI 200 options, and 3- and 10-year KTB futures.
  • KRX is tightening overall price limits for night sessions but doubling real-time order bands—aiming to curb big swings while keeping trades flowing smoothly despite thinner liquidity.

Korean Banks; Stick with Hana (086790 KS) And Woori (316140 KS)

By Victor Galliano

  • Our weighted metrics of share valuations, returns, capital adequacy and credit quality feed into a scorecard matrix; we look for opportunities where the risks are well discounted in current valuations
  • Woori Financial Group (316140 KS) remains the stand-out in terms of our matrix; this is based on valuation, dividend yield, and its superior credit quality relative to its peers
  • Hana Financial is second from top in our scorecard due to its attractive PBV ratio versus RoE, healthy dividend yield and sound credit quality; management should deliver improved medium-term returns

SK Biopharmaceuticals (326030 KS): Starts 2025 on Slower Note; Xcopri US Sales Growth Moderates

By Tina Banerjee

  • SK Biopharmaceuticals (326030 KS) announced muted 1Q25 result, with all key parameters, including revenue, operating profit, and net profit declining sequentially, as the Xcopri sales in the U.S. moderates.
  • Xcopri U.S. sales increased 3% QoQ, which is the lowest over the last one year, due to seasonal inventory drawdown, restructuring of major pharmacy chain, and high base effect.
  • SKBP considers Xcopri U.S. revenue moderation as ‘temporary’ and sees recovery in 2Q. However, high revenue exposure to the U.S. seems to be a serious headwind in current uncertain scenario.  

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Thailand: Valeura Energy Inc and more

By | Daily Briefs, Thailand

In today’s briefing:

  • Valeura Energy (TSX: VLE): FID at Wassana adds 8.6 mmbbl 2P reserves


Valeura Energy (TSX: VLE): FID at Wassana adds 8.6 mmbbl 2P reserves

By Auctus Advisors

  • • The 1Q25 production and cash position at the end of March were in line with previous indications.
  • However the adjusted working capital was ~US$15 mm higher than cash given an oil inventory increase of 0.89 mmbbl.
  • • Valeura has taken FID at Wassana (G10/48 licence), resulting in the conversion of 8.6 mmbbl 2C contingent resources into 2P reserves.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Singapore: Frasers Hospitality Trust, Mirxes Holding, UOB Kay Hian Holdings, SGX Rubber Future TSR20 and more

By | Daily Briefs, Singapore

In today’s briefing:

  • Frasers Hospitality Trust (FHT SP): Frasers Property & TCC Reload Scheme
  • Mirxes Pre-IPO: Challenges for Mass Adoption Become Clearer
  • Fraser Hospitality Trust (FHT SP): Frasers Property’s Light Scheme Offer
  • STI Banks Report Robust 1Q25 Financial Performance
  • Tariffs Add To Uncertainty In Global Tire Markets


Frasers Hospitality Trust (FHT SP): Frasers Property & TCC Reload Scheme

By David Blennerhassett

  • Frasers Hospitality Trust (FHT SP) (FHT) has announced a Scheme Implementation Deed was signed for the S-REIT’s privatisation by its current sponsor, Frasers Property Limited.
  • The Scheme Consideration is S$0.71/unit in cash against the latest adjusted NAV estimate of S$0.63904/unit (vs last NAV of S$0.64160/unit).
  • Back in September 2022, ~3% of units (~4.7% of minorities) voted against Frasers/TCC’s S$0.70/unit Offer. But only 18.8% of minorities actually voted. That deal just failed. 

Mirxes Pre-IPO: Challenges for Mass Adoption Become Clearer

By Ke Yan, CFA, FRM

  • After an IPO attempt two years ago, Mirxes filed an updated prospectus in an attempt to raise at least US$100m via a Hong Kong listing.
  • In our previous note, we analyzed its product pipelines and highlighted signs of commercialization challenges.
  • In this note, we note that the company expanded its clinical trial plans. Yet, more data shows that blockbuster-level uptakes are unlikely given the profile of its clinical data.

Fraser Hospitality Trust (FHT SP): Frasers Property’s Light Scheme Offer

By Arun George

  • Frasers Hospitality Trust (FHT SP) announced a scheme privatisation from Frasers Property Ltd (FPL SP) at S$0.71 cash and permitted distributions (estimated at S$0.0086 per unit).
  • The 2022 scheme failed because it narrowly missed the 75% approval threshold. The current offer is light compared to the 2022 offer in several ways.
  • Emerging retail opposition could make satisfying the headcount test challenging. The offer has not been declared final, and a bump is possible.

STI Banks Report Robust 1Q25 Financial Performance

By Geoff Howie

  • In 1Q25, the three STI banks reported a combined Net Interest Income of S$8.4 billion and non-interest income of S$4.8 billion.
  • Over the first four months of 2025, the STI banks led share buybacks with a combined S$550 million consideration.
  • DBS, UOB, and OCBC have announced capital management initiatives including share buybacks and special dividends for 2025.

Tariffs Add To Uncertainty In Global Tire Markets

By Farah Miller

  • A new probe from EU on Chinese tire due to start May 19  
  • Lack of clarity on the range of tires under the scope of US auto tariff  
  • Lobbying to suspend or delay the implementation of auto tariff 

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Industrials: Nippon Road, Sumitomo Mitsui Construction, SMPP Ltd, Epco Co Ltd, CIMC Enric Holdings, Ravi Infrabuild Projects Ltd, World Holdings, Harmonic Drive Systems, KULR Technology Group and more

By | Daily Briefs, Industrials

In today’s briefing:

  • [Japan M&A] – Three+ Years Later, Shimizu Comes In To Buy Out Minorities in Nippon Road (1884)
  • [Japan M&A/Activism] Infroneer To Buy Out Activist Target Sumi Mits Construction (1821) Cheapish
  • Nippon Road (1884 JP): Shimizu Corp (1803 JP) Tender Offer Is Light but Likely Done
  • SMPP Ltd Pre-IPO – In the Right Space (Defence), at the Right Time but Growth Has Been Inconsistent
  • Epco Co Ltd (2311 JP): Q1 FY12/25 flash update
  • CIMC Enric (3899 HK): Deep Value
  • Ravi Infrabuild Projects Ltd Pre-IPO Tearsheet
  • World Holdings (2429 JP): Q1 FY12/25 flash update
  • Harmonic Drive Systems (6324 JP): Full-year FY03/25 flash update
  • Kulr Technology: Battery Technology Company Looks Overheated


[Japan M&A] – Three+ Years Later, Shimizu Comes In To Buy Out Minorities in Nippon Road (1884)

By Travis Lundy

  • In February 2022, Shimizu Corp (1803 JP) bought an additional 25% to get to 50.1% of Nippon Road (1884 JP). It wasn’t a great price.
  • It was, however, a good trade to buy the dip after, as recommended. I expected Shimizu to come back in one to three years. It took three. 
  • Like last time, the price is light. The multiple is low. There are no synergies in the price analysis, in specific violation of the METI Fair M&A/CorpTakeover Guidelines.  Bah humbug.

[Japan M&A/Activism] Infroneer To Buy Out Activist Target Sumi Mits Construction (1821) Cheapish

By Travis Lundy

  • Noted activist Yoshiaki MURAKAMI and associates owned ~12.5% in March 2024, perhaps a tad more. Now they own ~29%. 
  • Integrated Construction Co INFRONEER Holdings (5076 JP) – congenitally allergic to paying full price for acquisitions – is buying Sumitomo Mitsui Construction (1821 JP) well below FAs’ DCF range midpoints.
  • But MURAKAMI-san has tossed his cards in, agreeing to tender. This looks like it gets done, but there are interesting angles.

Nippon Road (1884 JP): Shimizu Corp (1803 JP) Tender Offer Is Light but Likely Done

By Arun George

  • Nippon Road (1884 JP) has recommended a tender offer from Shimizu Corp (1803 JP) at JPY2,520, a 16.2% premium to the undisturbed price.
  • The offer represents an all-time high and is 26.0% higher than the 2022 partial tender offer price. However, it is light compared to peer multiples.
  • The offer is below the midpoint of the target IFA DCF valuation range. However, the required minority acceptance rate is not onerous, and this is a done deal. 

SMPP Ltd Pre-IPO – In the Right Space (Defence), at the Right Time but Growth Has Been Inconsistent

By Sumeet Singh

  • SMPP Ltd is planning to raise about US$476m through its upcoming IPO in India.
  • SMPP Ltd. designs and manufactures defence equipment, specialising in ammunition components and personal protection products for the Indian armed forces, police, and security agencies.
  • In this note, we look at the company’s past performance.

Epco Co Ltd (2311 JP): Q1 FY12/25 flash update

By Shared Research

  • In Q1 FY12/25, revenue increased by 10.3% YoY to JPY1.5bn, while operating profit declined by 19.8%.
  • Renewable Energy Service business revenue rose 54.3% YoY, with recurring profit returning to the black from a prior loss.
  • Design Service business revenue increased 0.5% YoY, with a 4.3% rise in recurring profit due to efficiency improvements.

CIMC Enric (3899 HK): Deep Value

By Osbert Tang, CFA

  • CIMC Enric Holdings (3899 HK)‘s YTD decline in share price provides an opportunity to pick up this name, which sees a solid sequential earnings improvement this year. 
  • 1Q25 revenue growth accelerated to 24.4%, from 2.9% in 2H25. While 1Q25 new orders have dropped, there is a sharp rebound in Apr, with a more positive 2H25 outlook.
  • At 9.3x FY25 PER after going ex-dividend (27 May), it is cheap relative to 14.7% 3-year EPS CAGR. The stock is also trading at the low-bound of the 3-year range.  

Ravi Infrabuild Projects Ltd Pre-IPO Tearsheet

By Rosita Fernandes

  • Ravi Infrabuild Projects Ltd (1607447D IN)  (RIPL) is looking to raise about US$178m in its upcoming India IPO. The bookrunners for the deal are Axis, Motilal.
  • RIPL is one of the leading infrastructure construction firms in India, experienced in executing structural projects such as flyovers, bridges, railways, highways, and expressways.
  • RIPL had grown 16.6x in terms of its average order size, reaching INR2,577m (as on Dec 2024), as per the company.

World Holdings (2429 JP): Q1 FY12/25 flash update

By Shared Research

  • Revenue increased to JPY63.5bn (+15.8% YoY), with operating profit at JPY2.5bn (+292.9% YoY) and recurring profit at JPY2.4bn (+298.0% YoY).
  • Products HR business revenue was JPY28.1bn (+9.7% YoY), with segment profit at JPY750mn (+202.4% YoY).
  • Real Estate business revenue was JPY12.5bn (+61.2% YoY), with segment profit at JPY1.5bn (+206.9% YoY).

Harmonic Drive Systems (6324 JP): Full-year FY03/25 flash update

By Shared Research

  • Consolidated sales for FY03/25 declined 0.3% YoY to JPY55.6bn, with operating profit down 94.4% YoY.
  • Q4 parent orders increased 22.9% YoY to JPY8.0bn, driven by industrial robots and semiconductor equipment orders.
  • HDSI forecasts 1H FY03/26 sales at JPY27.0bn, with operating profit of JPY300mn, recovering from previous losses.

Kulr Technology: Battery Technology Company Looks Overheated

By J Capital Research

  • Kulr Technology (NASDAQ: KULR) makes technology to manage heat levels in batteries.
  • We believe KULR has failed at building a product relevant to a large market.
  • Now, with less than $11 mln in annual revenue after 12 years of trying, KULR appears to have built a cottage industry in promoting its own stock.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars